Get the Stockscreener App
1.91
1.06%
0.02
Tscan Therapeutics Inc stock is traded at $1.91, with a volume of 270.19K.
It is up +1.06% in the last 24 hours and up +9.14% over the past month.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
See More
Previous Close:
$1.89
Open:
$1.9
24h Volume:
270.19K
Relative Volume:
0.71
Market Cap:
$100.22M
Revenue:
$21.05M
Net Income/Loss:
$-89.22M
P/E Ratio:
-1.067
EPS:
-1.79
Net Cash Flow:
$-64.50M
1W Performance:
+6.11%
1M Performance:
+9.14%
6M Performance:
-0.52%
1Y Performance:
-66.07%
1-Day Range:
$1.86
$1.96
1-Week Range:
$1.73
$1.96
52-Week Range:
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Name
Tscan Therapeutics Inc
Sector
Industry
Phone
857-399-9500
Address
830 WINTER STREET, WALTHAM
Compare TCRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.91 | 107.25M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-24 | Initiated | BTIG Research | Buy |
| May-13-24 | Initiated | Needham | Buy |
| Jun-22-23 | Initiated | Wedbush | Outperform |
Tscan Therapeutics Inc Stock (TCRX) Latest News
Can a trend reversal in TScan Therapeutics Inc. lead to recoveryPortfolio Value Summary & Consistent Profit Trading Strategies - Newser
What institutional flow reveals about TScan Therapeutics Inc.July 2025 Update & Accurate Technical Buy Alerts - Newser
TScan Therapeutics Inc. stock prediction for this week2025 Performance Recap & Community Trade Idea Sharing - Newser
How to interpret RSI for TScan Therapeutics Inc. stockInflation Watch & Daily Oversold Bounce Ideas - Newser
Custom strategy builders for tracking TScan Therapeutics Inc.July 2025 Analyst Calls & Free Daily Entry Point Trade Alerts - Newser
Leading vs lagging indicators on TScan Therapeutics Inc. performanceTrade Risk Assessment & Reliable Breakout Stock Forecasts - Newser
Does TScan Therapeutics Inc. show high probability of reboundJuly 2025 Institutional & Verified Short-Term Plans - Newser
Is TScan Therapeutics Inc. trending in predictive chart modelsWeekly Risk Summary & Free Daily Entry Point Trade Alerts - Newser
What indicators show strength in TScan Therapeutics Inc.July 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
Should I set a stop loss on TScan Therapeutics Inc.2025 Price Momentum & Real-Time Volume Analysis - خودرو بانک
What are TScan Therapeutics Inc.’s earnings expectations2025 Support & Resistance & Verified Short-Term Plans - خودرو بانک
How high can TScan Therapeutics Inc. stock go2025 Dividend Review & Weekly Market Pulse Updates - Newser
Has TScan Therapeutics Inc. found a price floor2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Should you avoid TScan Therapeutics Inc. stock right nowJuly 2025 Momentum & Breakout Confirmation Trade Signals - خودرو بانک
Understanding TScan Therapeutics Inc.’s price movementTrade Entry Summary & Safe Investment Capital Preservation Plans - Newser
Is TScan Therapeutics Inc. stock poised for growthJuly 2025 Selloffs & Free Community Consensus Stock Picks - Newser
What Fibonacci levels say about TScan Therapeutics Inc. rebound2025 Market Outlook & Real-Time Market Trend Scan - Newser
Does TScan Therapeutics Inc. align with a passive investing strategyWeekly Gains Report & Risk Managed Investment Signals - خودرو بانک
Visualizing TScan Therapeutics Inc. stock with heatmapsWeekly Profit Summary & Daily Chart Pattern Signals - Newser
What data driven models say about TScan Therapeutics Inc.’s future2025 Momentum Check & Risk Controlled Stock Pick Alerts - Newser
Is TScan Therapeutics Inc. a strong growth stockJuly 2025 EndofMonth & Weekly Top Stock Performers List - خودرو بانک
Real time scanner hits for TScan Therapeutics Inc. explained2025 Top Decliners & Daily Profit Focused Screening - Newser
Can TScan Therapeutics Inc. deliver consistent dividendsQuarterly Portfolio Review & Breakout Confirmation Alerts - خودرو بانک
Sector ETF performance correlation with TScan Therapeutics Inc.Market Volume Summary & Short-Term Trading Opportunity Alerts - Newser
TScan Therapeutics shares rise 2.29% intraday after announcing participation in upcoming investor conferences. - AInvest
Is TScan Therapeutics Inc. forming a bottoming baseWeekly Trade Review & High Win Rate Trade Alerts - Newser
Pattern recognition hints at TScan Therapeutics Inc. upsideProfit Target & Trade Opportunity Analysis - Newser
TScan Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Cancer-Fighting TCR-T Developer TScan Therapeutics to Present at Two Major Healthcare Conferences - Stock Titan
Is TScan Therapeutics Inc. trading at a discountDip Buying & AI Powered Buy and Sell Recommendations - خودرو بانک
Why TScan Therapeutics Inc. is moving todayMarket Performance Report & Reliable Breakout Forecasts - Newser
How to track smart money flows in TScan Therapeutics Inc.Take Profit & Reliable Price Action Trade Plans - Newser
What candlestick patterns are forming on TScan Therapeutics Inc.Market Movement Recap & Community Supported Trade Ideas - Newser
How to monitor TScan Therapeutics Inc. with trend dashboards2025 Historical Comparison & Daily Entry Point Trade Alerts - Newser
Real time alert setup for TScan Therapeutics Inc. performanceTrade Analysis Report & Short-Term Trading Opportunity Alerts - Newser
Published on: 2025-09-03 01:05:15 - Newser
Can TScan Therapeutics Inc. deliver alphaBond Market & Weekly Momentum Picks - خودرو بانک
Is TScan Therapeutics Inc. stock a value trap2025 Technical Patterns & Advanced Swing Trade Entry Plans - khodrobank.com
A | What are the risks of holding TScan Therapeutics, Inc.Quarterly Market Summary & Weekly High Return Stock Forecasts - خودرو بانک
Deutsche Bank AG Increases Position in TScan Therapeutics, Inc. $TCRX - Defense World
Support Test: Is TScan Therapeutics Inc. a momentum stockJuly 2025 Final Week & Weekly Stock Breakout Alerts - خودرو بانک
Tscan Therapeutics Inc Stock (TCRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tscan Therapeutics Inc Stock (TCRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
May 20 '25 |
Buy |
1.20 |
1,200,000 |
1,440,000 |
7,946,141 |
| Lynx1 Capital Management LP | 10% Owner |
Dec 13 '24 |
Buy |
2.90 |
100,000 |
290,140 |
5,357,347 |
| Lynx1 Capital Management LP | 10% Owner |
Dec 12 '24 |
Buy |
3.01 |
31,800 |
95,629 |
5,257,347 |
| Lynx1 Capital Management LP | 10% Owner |
Nov 15 '24 |
Buy |
4.34 |
947 |
4,114 |
5,225,547 |
| Klencke Barbara | Director |
Sep 23 '24 |
Buy |
5.29 |
5,000 |
26,450 |
45,000 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):